Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Apr 25, 2018
| Rachel Schwartz
Together! Engaging Women in Health Policy
Blog
Apr 16, 2018
| Erica Klinger
Restricted Access Drug Programs Impeding Patient Access to Generic Drugs: Myths and Facts Regarding Maine LD 1280
Blog
Apr 13, 2018
| Erik Komendant
Cotton-McCaskill PACED Act Would Help Patients Gain Access to More Affordable Generics
Blog
Apr 9, 2018
| Jeff Francer
AAM Has Adopted a Code of Business Ethics. Here’s What That Means.
Blog
Apr 1, 2018
| Jewel Smith
Why Membership Matters
Blog
Mar 28, 2018
| Erica Klinger
Skyrocketing Drug Prices: What's Driving Up Costs?
Blog
Feb 28, 2018
| Rachel Schwartz
Recap of Access! 2018 — Delivering on the Promise of Generics and Biosimilars (Part 3)
Blog
Feb 27, 2018
| Erik Komendant
The 180-Day Rule Supports Generic Competition. Here’s How.
Blog
Feb 23, 2018
| Rachel Schwartz
Recap of Access! 2018 — Chip's Call to Action (Part 2)
Blog
Feb 19, 2018
| Rachel Schwartz
Recap of Access! 2018 — Successes From the Past Year (Part 1)
Blog
Feb 2, 2018
| Kristin Murphy
Help Pass the CREATES Act
Blog
Jan 31, 2018
| Erica Klinger
Dear Mr. President
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action